Mr. Narsimha Shibroor Kamath's most recent trade in Bliss GVS Pharma Ltd. was a Acquisition of 77,000 Equity Shares done at an average price of Rs. 127.5 . Disclosure was reported to the exchange on Feb. 21, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Mr. Narsimha Shibroor Kamath in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 21 Feb 2025 | 77,000 | 32,414,024 (30.76%) | 0.07% | 127.5 | 9,819,293 | 18 Feb 2025 18 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 21 Feb 2025 | 23,000 | 32,437,024 (30.78%) | 0.02% | 133.6 | 3,072,625 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 01 Mar 2023 | 300,000 | 31,957,024 (30.68%) | 0.29% | 79.1 | 23,724,714 | 24 Feb 2023 24 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 18 Feb 2023 | 100,000 | 31,657,024 (30.39%) | 0.10% | 78.0 | 7,797,497 | 16 Feb 2023 16 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 18 Feb 2023 | 200,000 | 31,557,024 (30.30%) | 0.19% | 76.9 | 15,386,242 | 15 Feb 2023 15 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Disposal | 30 Mar 2022 | 3,000,000 | 31,357,024 (30.24%) | 2.89% | 67.0 | 200,850,000 | 29 Mar 2022 29 Mar 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |